DRI Healthcare Trust Closes C$104 Million Bought Deal Public Offering Including Full Exercise of Over-Allotment Option
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 20, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the “Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announces the closing of its previously announced bought deal public offering of units, including […]
DRI Healthcare Trust Announces C$90 Million Bought Deal Public Offering of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 12, 2023 (GLOBE NEWSWIRE) — DRI Healthcare Trust (TSX: DHT.UN/DHT.U) (the “Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced today that it has entered into an agreement with a syndicate of underwriters […]
DRI Healthcare Trust Reports Second Quarter 2023 Results
– Continued strong portfolio performance with 16% royalty income growth over prior year period – – Deployment of US$284 million since April 1 showcases Trust’s ability to execute – – Capital inflows of US$339 million from royalty sale, debt repayment and follow-on equity offering combined with attractive credit facilities provide significant cash for deployment – […]
DRI Healthcare Trust Announces Acquisition of a Second Royalty Interest in the Worldwide Sales of ORSERDU® (elacestrant) and Updates Long-Term Guidance
– Proceeds from follow-on offering quickly redeployed into value accretive transaction – – DRI Healthcare’s third significant royalty acquisition within six weeks – – Now expecting mid-teens total income CAGR through 2025 and low single digit total income CAGR through 2030, excluding any new transactions – TORONTO, Aug. 14, 2023 /CNW/ – DRI Healthcare Trust […]
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences
TORONTO, July 25, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that the Trust intends to participate in the following investor conferences in 2023: Canaccord Genuity Annual Growth Conference Date: August 9, 2023 Presentation time: 9:30 am ET City: Boston, Massachusetts Event URL: https://www.canaccordgenuity.com/capital-markets/about-us/events/43rd-annual-growth-conference/ CIBC 22nd Annual […]
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 15, 2023
TORONTO, July 25, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its second quarter 2023 financial results on Tuesday, August 15, 2023, at 8:00 a.m. ET. The Trust will report its financial results on Monday, August 14, 2023, after market […]
DRI Healthcare Trust Completes C$98 Million Bought Deal Public Offering of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 19, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the “Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced today that it has completed its previously announced bought deal public offering of […]
DRI Healthcare Trust Announces C$85 Million Bought Deal Public Offering of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 12, 2023 (GLOBE NEWSWIRE) — DRI Healthcare Trust (TSX: DHT.UN/DHT.U) (the “Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced today that it has entered into an agreement with a syndicate of underwriters […]
DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of VONJO® (pacritinib)
– Uncapped deal structure complements current VONJO royalty entitlement – – Now projecting Total Income CAGR at high end of our 7-9% guidance through 2025 and flat to slightly growing Total Income until 2030 – – The transaction extends DRI’s overall portfolio duration to over 10 years – TORONTO, July 7, 2023 /CNW/ – DRI […]
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Net Sales of Orserdu™ (elacestrant) and Reiterates Long-Term Cash Receipts Outlook
– Patent-protected exclusivity and uncapped deal structure offers attractive return profile – – Acquisition generates substantial near-term cash flows and long-term portfolio growth – – DRI Healthcare expects flat to slightly growing cash receipts through 2030 – TORONTO, June 30, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the “Trust”), a global leader in providing […]